Issue 91, 2021

Immunogenic cell death inducers for enhanced cancer immunotherapy

Abstract

Inducing the immunogenic cell death (ICD) of cancer cells is an important method to improve the immunogenicity of tumor cells for enhanced cancer immunotherapy. Therefore, we discuss the ICD process and then highlight various ICD inducers and strategies for triggering the ICD of cancer cells. We hope that this Feature Article will inspire readers to develop more effective ICD inducers.

Graphical abstract: Immunogenic cell death inducers for enhanced cancer immunotherapy

Article information

Article type
Feature Article
Submitted
19 Aug 2021
Accepted
05 Oct 2021
First published
05 Oct 2021

Chem. Commun., 2021,57, 12087-12097

Immunogenic cell death inducers for enhanced cancer immunotherapy

Y. Li, X. Liu, X. Zhang, W. Pan, N. Li and B. Tang, Chem. Commun., 2021, 57, 12087 DOI: 10.1039/D1CC04604G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements